TOG Review (RCOG Journal)
MRCOG Part 2
Sexual and Reproductive Health
A review of contraceptive methods for women with cardiac disease
Key Statistics
- 17–33% — Maternal mortality, pulmonary hypertension (2009 SR)
- 99.8% — LNG-IUS efficacy yr 1 (> sterilisation 99.5%)
- 1–2/1000 — Uterine perforation risk at IUD/IUS insertion
Don't-miss facts
-
Cardiac disease = leading indirect cause of UK maternal death; pregnancy contraindicated (class 4) in pulmonary hypertension, severe heart failure, severe left heart obstruction
-
COC UKMEC 4: personal VTE history, impaired cardiac function/heart failure, atrial fibrillation, ischaemic heart disease, previous ischaemic stroke, migraine with aura, BP ≥160/≥100. Avoid estrogen in cyanotic heart disease and mechanical valves
-
POP is suitable for almost any woman — no ↑VTE, hypertension, stroke or MI risk; exception is bosentan
-
Bosentan: use injectable progestogen or a non-hormonal method; oral/implantable progestogens and combined methods are ineffective (CYP2C9/3A4 induction)
-
LNG-IUS 99.8% effective > sterilisation 99.5%; both IUD and IUS can be inserted while anticoagulated and at any point in the cycle
-
Copper IUD works immediately; LNG-IUS immediate only if inserted within 7 days of a period — otherwise 7 days of barrier cover
-
Vasovagal bradycardia after insertion in 1.8% (Farmer & Webb, n=545); have atropine, adrenaline and oxygen ready. High-risk cardiac women: insert in hospital with cardiac monitoring and cardiac anaesthetic back-up
-
Intrauterine contraception is UKMEC 4 in Fontan circulation and pulmonary vascular disease; IV antibiotic prophylaxis needed for previous endocarditis or prosthetic valves
Typical-use failure in first year
Vasectomy 0.15% · LNG-IUS 0.2% · sterilisation 0.5% · copper IUD <0.8% Diaphragm/cap + spermicide 12% · male condom 18%
Female condom 22% · withdrawal 22% · rhythm/calendar 24% — not suitable in cardiac disease
Abbreviation Key
- WHOMEC — WHO Medical Eligibility Criteria for Contraceptive Use
- IUS — levonorgestrel intrauterine system
- UKMEC — UK Medical Eligibility Criteria for Contraceptive Use
- VTE — venous thromboembolism
- FSRH — Faculty of Sexual and Reproductive Healthcare
- MI — myocardial infarction
- LARC — long-acting reversible contraception
- DOAC — direct oral anticoagulant
- COC — combined oral contraceptive
- INR — international normalised ratio
- POP — progestogen-only pill
- STI — sexually transmitted infection
- IUD — (copper) intrauterine device
- BMD — bone mineral density
Source: Jakes AD, Coad F, Nelson-Piercy C. A review of contraceptive methods for women with cardiac disease. The Obstetrician & Gynaecologist 2018;20:113–120. doi:10.1111/tog.12446
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).